Kidney disease rarely appears on lists of psychiatric comorbidities, yet the organ-level toll of conditions like schizophrenia and bipolar disorder may be quietly compounding an already serious longevity gap. This meta-analysis of 48 studies quantifies that overlooked burden and points toward a mechanism-rich intersection that clinicians — and patients — have largely ignored.
Drawing on six major databases and applying random-effects pooling, researchers found that people with severe mental illness (SMI) carried a pooled chronic kidney disease (CKD) prevalence of approximately 8%, with those diagnosed specifically with bipolar disorder reaching prevalence estimates as high as 26%. The incidence rate across SMI populations was 26.83 new CKD cases per 1,000 person-years. Most strikingly, the odds of CKD among people with SMI were 2.33-fold higher than in matched general populations (95% CI: 1.70–3.21) — a statistically robust signal that held across the heterogeneous study pool.
This finding lands in a well-established but underappreciated context: people with SMI already face a 15–20 year reduction in life expectancy, with cardiovascular disease historically commanding the most clinical attention. CKD introduces a compounding layer that is harder to detect, progresses silently, and is worsened by several pharmacological agents commonly prescribed in psychiatric care — notably lithium and certain antipsychotics with metabolic side effects. The bidirectional relationship is also plausible; uremic toxins and glomerular dysfunction can exacerbate neuropsychiatric symptoms, potentially creating a feedback loop that neither psychiatry nor nephrology has adequately owned. The wide confidence intervals around the pooled prevalence estimate (5–18%) signal substantial between-study heterogeneity, reflecting inconsistent CKD staging criteria and population differences. As a meta-analysis of observational data, causality remains unresolved. Nonetheless, the effect size is large enough to warrant systematic renal function screening as a routine component of SMI care — a practice not yet universally adopted.